Compare Coinbase Global, Inc. (COIN) vs Twist Bioscience Corp (TWST) Price & Performance

Coinbase Global, Inc.Trade

Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Coinbase Global, Inc. vs Twist Bioscience Corp — how do they compare? Coinbase Global, Inc. trades at $150.54 (market cap $39.20B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Coinbase Global, Inc. is far larger — about 5.1× Twist Bioscience Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Coinbase Global, Inc. nearer its low. Which is the better fit depends on your goals.

	COIN	TWST
Market Cap	$39.20B	$7.72B
Sector	Technology	Health
52-Week High	$387.27	$124.88
52-Week Low	$141.09	$24.16
Enterprise Value	$36.85B	$7.65B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

COIN

NYC Council probes deceptive marketing by prediction market platforms amid legal battles.CNBC · 4 hours agoBearish Circle shares rise 5% on strong Q2 results and upcoming Arc mainnet launch24/7 Wall Street · 19 hours agoBullish Polymarket hires top executives, revamps marketing amid CFTC probe ahead of NFL and midterm season.CNBC · 1 day agoNeutral View details →

TWST

View details →

About Coinbase Global, Inc.

Coinbase Global, Inc. is a regulated cryptocurrency company that provides customers around the world with a platform for buying, selling, transferring, and storing digital assets. The Company offers a variety of products and services that enable individuals, businesses, and developers to participate in the cryptoeconomy.

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.